Electrolytes are essential for the management of various kidney pathologies, both hereditary and acquired, including rare diseases [1, 2]. In this specific context, they do not represent simple supplementations, but true treatments. The doses that need to be used often exceed doses used for standard supplementation. Limited availability and the frequent need to use compounded hospital formulations complicate access to these treatments.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with de
Contact de, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack